Back to 
Savant Capital, LLC
Savant Capital, LLC
AMRX
3 quarters
Position history for Savant Capital, LLC's holdings in Amneal Pharmaceuticals, Inc.
Yes. Savant Capital holds 10,805 shares of AMRX (Amneal Pharmaceuticals), worth $217,614, as of its Q3 2026 13F filing. It opened the position in Q3 2026.
Current Value
$217,614
Current Shares
10,805
Total Value Change
+$151,329
Total Shares Change
-133
Quarter-by-Quarter History
Other major holders of AMRX: BlackRock, Inc., Vanguard Group Inc., TPG GP A, LLC, Vanguard Portfolio Management LLC